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INTRODUCTION: Chronic degenerative disease 
such as cancer, Parkinson’s disease and 
cardiovascular diseases are the leading cause of 
mortality worldwide1. According to the World 
Health Organisation, chronic diseases constitute 
85%2 of deaths in the United Kingdom; they also 
cause permanent loss of cells and organ 
dysfunction. Cell-based therapies provide a diverse 
range of treatment options, and spraying of cells 
directly to the affected area is one delivery 
mechanism that has been shown to promote cell 
proliferation and cell viability, as cells are 
delivered on a layer-by-layer basis in a fast and 
controlled manner, thus accelerating the healing 
process3,4. The requirements of cell spraying are 
specific to the tissue being treated, especially due 
to geometric variability between tissues. It is 
essential to understand the link between cell 
spraying output (e.g. volume of cells delivered, 
surface area and the spatial distribution of 
delivery), and input (air pressure, nozzle 
dimensions, volume flow rate of cell suspension); 
we aim to use computational modelling as a tool to 
inform these relationships, enabling organ-specific 
application of spray systems for cell delivery. Here 
we present a case study based on spraying cells to 
the back a human eye, a therapeutic option for 
treating blindness. 
METHODS: We use the CFD solver, STAR-
CCM+®, to enable spatial simulations of spraying 
in realistic clinical geometries. The human eye is 
represented by a three dimensional hemisphere 
with a diameter of 25 mm, where an injector with a 
nozzle diameter of 0.6 mm, positioned using 
cylindrical coordinate system at (3,7,0) from the 
centre of the geometry provides the location at 
which cells are sprayed into the eye. Typically a 
cell suspension (cells plus supporting matrix 
components) is injected at a rate of 2ml/s at a 
spraying angle of 120° for 2s, with an air pressure 
of 2 bars applied at the injector (these are realistic 
parameters used for commercially available cell-
delivery spraying systems3). A continuum 
mechanics approach was used with the cellular 
suspension drops described using a multiphase 
model, and the spatial distribution of drops tracked 
in time. Boundary conditions on the hemisphere 
and nozzle input were chosen to represent the input 
parameters described above  
RESULTS: For given output parameters, we are 
able to predict the thickness of the cellular 
suspension (see Fig 1), which varied over 1.3-2mm 
over the time course of one spraying event. The 
thickness and variability of this layer thickness is 
determined by the flow rate of delivery and 
spraying pressure. The section of the eye that is 
covered is determined by the spraying direction 
and nozzle geometry, and the model enables these 
parameters to be varied to inform spray operation.  
 
 
Fig. 1: Image of the hemisphere showing fluid film 
thickness distribution over the surface area. 
DISCUSSION & CONCLUSIONS: The 
computational models developed provide insight 
into the link between spraying pressure and flow 
rate, and the spatial distribution of delivered cells. 
These simulations provide a starting point for 
building standardised computational models 
relevant to more complex geometries and spraying 
scenarios, with a view to informing cell delivery 
parameters in a way that minimises costly and time 
consuming experimentation. 
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